Stuart Hannah

Dr Stuart Hannah is a health technology entrepreneur focused on transforming patient outcomes through rapid diagnostics to combat antimicrobial resistance. He is the CEO and co-founder of Microplate Dx, developing scalable, inclusive platform diagnostics to address one of healthcare’s most urgent global challenges. Stuart holds a PhD in Electronic & Electrical Engineering, has raised over £7 million to date for Microplate Dx and has over a decade of experience in biosensors and diagnostic technologies.